PreprintAll rights reservedbioRxiv
Vorinostat Can Reduce an Ongoing Fibrosis and Preserve Key Liver Metabolic Functions by Selectively Altering Mesenchymal Cell Differentiation
- 1Stanford
Related
- Squeezing Treatment-Induced Metabolic Alterations in Melanoma Cells Are Accompanied by Impaired Cluster of Differentiation 8-Positive T Cell and Natural Killer Cell Antitumor Effector Functions
- BIRC3 facilitates osteogenic differentiation of bone marrow mesenchymal stem cells via NGFR/β-catenin signalling axis
- Comparative analysis of select 3D human mesenchymal stromal cell-derived spheroid models for adipogenic differentiation.
- Oxytocin/oxytocin receptor signaling in mesenchymal stem cell differentiation: current evidence and future perspectives on osteogenesis, adipogenesis, and chondrogenesis
- PTHrP suppresses BMP2-induced osteochondral differentiation and preserves cartilage phenotype in mesenchymal stem cells via inactivating PI3K-AKT signaling.
BibTeX
@misc{guan2026vorinostat,
title = {{Vorinostat Can Reduce an Ongoing Fibrosis and Preserve Key Liver Metabolic Functions by Selectively Altering Mesenchymal Cell Differentiation}},
author = {Y. GUAN and G. Peltz},
howpublished = {bioRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.02.763750},
url = {https://www.biorxiv.org/content/10.64898/2026.11.02.763750v1},
}
RIS
TY - UNPB
TI - Vorinostat Can Reduce an Ongoing Fibrosis and Preserve Key Liver Metabolic Functions by Selectively Altering Mesenchymal Cell Differentiation
AU - Y. GUAN
AU - G. Peltz
PY - 2026
DA - 2026/11/02
PB - bioRxiv
DO - 10.64898/2026.11.02.763750
UR - https://www.biorxiv.org/content/10.64898/2026.11.02.763750v1
ER -